Home
>
National Drug Code (NDC)
>
TRANDOLAPRIL
TRANDOLAPRIL - 64720-162-10 - (TRANDOLAPRIL)
Drug Information of TRANDOLAPRIL
| Product NDC: | 64720-162 |
| Proprietary Name: | TRANDOLAPRIL |
| Non Proprietary Name: | TRANDOLAPRIL |
| Active Ingredient(s): | 2 mg/1 & nbsp; TRANDOLAPRIL |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of TRANDOLAPRIL
| Product NDC: | 64720-162 |
| Labeler Name: | CorePharma, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077256 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070613 |
Package Information of TRANDOLAPRIL
| Package NDC: | 64720-162-10 |
| Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (64720-162-10) |
NDC Information of TRANDOLAPRIL
| NDC Code | 64720-162-10 |
| Proprietary Name | TRANDOLAPRIL |
| Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (64720-162-10) |
| Product NDC | 64720-162 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | TRANDOLAPRIL |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20070613 |
| Marketing Category Name | ANDA |
| Labeler Name | CorePharma, LLC |
| Substance Name | TRANDOLAPRIL |
| Strength Number | 2 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
